Tobin Jack J 4

What Happened Jack J. Tobin, MD and Chief Accounting Officer of CME Group, reported the vesting and receipt of 608 performance shares on March 15, 2026 (award code A) at a fair value of $311.40 per share, totaling $189,331. To satisfy tax withholding obligations (code F), he surrendered 179 of those shares at the same per-share value, representing $55,741. Net of withholding, Tobin received approximately 429 shares (about $133,591).

Key Details

• Transaction date(s) and price(s): March 15, 2026 — 608 shares @ $311.40 (award); 179 shares @ $311.40 (surrender for tax withholding).
• Net change: +429 shares (608 awarded − 179 surrendered), net value ≈ $133,591.
• Shares owned after transaction: Not disclosed in the Form 4 filing.
• Footnotes: Vesting reflects performance shares granted in 2022 under CME’s Omnibus Stock Plan, earned based on total shareholder return vs. the S&P 500 for the three-year period Jan 1, 2023–Dec 31, 2025. Surrendered shares were used to fulfill tax withholding.
• Timeliness: Reported on March 17, 2026 for a March 15, 2026 transaction — filed within the typical two business-day Form 4 window.

Context This was a vesting of performance-based equity (an award), not an open-market buy or sell. Surrendering shares to cover tax withholding is a common administrative step and does not necessarily signal a decision to divest. Performance-share vesting reflects compensation tied to multi-year relative TSR performance rather than a direct insider market purchase.